|
Abbott Announces Positive Three-Year Data on Its Fully Bioabsorbable Stent Technology
|
17 November 2009 |
|
Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
|
13 November 2009 |
|
Abbott Completes Acquisition of Evalve, Inc.
|
04 November 2009 |
|
Abbott completes acquisition acquisition of privately held eye care company Visiogen
|
29 October 2009 |
|
Abbott Completes Visiogen Acquisition
|
21 October 2009 |
|
Abbott Reports 16.5 Percent Earnings Growth in Third Quarter
|
14 October 2009 |
|
Abbott to Acquire Solvay Pharmaceuticals Business
|
28 September 2009 |
|
Results from Abbott's PROSPECT Study Provide New Insight
|
25 September 2009 |
|
Abbott Announces Approval in China for Next-Generation XIENCE V(R) Drug Eluting Stent
|
14 September 2009 |
|
Abbott to Acquire Evalve, Inc., a Leader in Minimally Invasive Cardiac Valve Repair Technology
|
11 September 2009 |
|
Abbott Again Named One of the 'Best Places to Launch a Career' by BusinessWeek
|
08 September 2009 |
|
Abbott to Acquire Visiogen, Expanding Vision Care Portfolio
|
03 September 2009 |
|
Abbott Launches Next-Generation XIENCE PRIME(TM) Drug Eluting Stent in International Markets
|
01 September 2009 |
|
Abbott to Collaborate With Pfizer Inc on Companion Diagnostic Test
|
28 August 2009 |
|
Health Canada Approves Abbott's XIENCE V(R) Drug Eluting Stent
|
25 August 2009 |
|
Abbott Partners With Beech-Nut to Provide New Parents with Nutrition Education and Support
|
11 August 2009 |
|
Abbott to Acquire Nutrition Businesses, Expanding Presence in India
|
29 July 2009 |
|
Abbott and GSK to Collaborate on Molecular Diagnostic Test
|
14 July 2009 |
|
Abbott Initiates Trial of Next-Generation XIENCE PRIME(TM) Drug Eluting Stent
|
17 June 2009 |
|
Abbott Announces Launch of Next-Generation Embolic Protection System
|
13 June 2009 |